16 June 2021,   23:43
more
Russia authorises single-dose Sputnik Light COVID vaccine for use

Russia has authorised the one-shot Sputnik Light version of its COVID-19 vaccine for use, the Russian Direct Investment Fund (RDIF) said on Thursday, a move that could help vaccine supplies go further in countries with high infection rates, writes Reuters.

Developed by Moscow’s Gamaleya Institute, the slimmed-down vaccine, which the RDIF said is 79.4% effective against COVID-19 and costs under USD 10 a dose, has been earmarked for export and could increase the number of people with partial immunity.

One of its main potential uses is as a vaccine that can be shipped to a country in the grip of an acute outbreak which needs to be subdued quickly.

A Phase III clinical trial involving 7,000 people was under way in Russia, the United Arab Emirates, Ghana and other countries, the RDIF said. Interim results are expected later this month.

MORE HEADLINES